Israel stocks rise, led by Teva, ICL - MarketWatch
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Israel stocks at record; Biogen remarks cost Teva - MarketWatch
Teva Pharmaceutical Industries Stock Jumps on a Rare Bullish View | Barron's
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Drugmaker Teva Pharmaceuticals found guilty for contribution to opioid crisis - MarketWatch
Teva earnings preview: Opioid suits are 'key' - MarketWatch
TEVA — TradingView
Teva shares surge on corporate shake-up - MarketWatch
Teva's stock has tumbled over 8 sessions and Morgan Stanley says it could fall 16% more - MarketWatch
Teva Pharmaceuticals stock falls 11% after earnings miss - MarketWatch
Israel stocks rise as investors key on Teva, ICL - MarketWatch
TEVA — TradingView
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect - MarketWatch
Three health-care deals today are paying huge premiums - MarketWatch
Teva releases generic version of Mylan's EpiPen in limited doses in the U.S. - MarketWatch
Deckers racked up $2 billion in Ugg boots sales in record year; stock jumps 14% - MarketWatch
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Teva Pharmaceuticals - Wikipedia
Perrigo rejects Mylan, opening door for Teva - MarketWatch
Market News
Teva Pharmaceuticals - Crunchbase Company Profile & Funding
Israel stocks steady; Teva settles with Takeda - MarketWatch
What Kind Of Shareholders Hold The Majority In Teva Pharmaceutical Industries Limited's (NYSE:TEVA) Shares?
